Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03671421
Other study ID # B2016:066
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date September 11, 2018
Est. completion date November 30, 2024

Study information

Verified date April 2024
Source Panam Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main purpose of this study is to determine if there is a difference in graft re-injury/failure rates between participants that have had an ACL reconstruction with a STG, BPTB or QT autograft. Additionally, to compare quality of life, patient reported outcomes and functional performance after ACL reconstruction with STG, BPTB and QT.


Description:

The main purpose of this study is to determine if there is a difference in graft re-injury/failure rates between participants that have had an ACL reconstruction with a STG, BPTB or QT autograft. Additionally, to compare quality of life, patient reported outcomes and functional performance after ACL reconstruction with STG, BPTB and QT. Quasi-randomized clinical trial


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 297
Est. completion date November 30, 2024
Est. primary completion date November 30, 2024
Accepts healthy volunteers No
Gender All
Age group 14 Years to 50 Years
Eligibility Inclusion Criteria: - - confirmed diagnosis of a complete primary unilateral ACL rupture based on all of the following: - history of a traumatic injury episode - physical exam findings of increased anterior translation of the tibia on the femur (Lachman test and/or anterior drawer test) - positive pivot shift test - patients must be 14 to </= 50 years (at time of surgery) - x-rays showing skeletal maturity (i.e. tibial tubercle fused) and no fractures - MRI prior to surgery (note: if the radiologist's report states an incomplete or partial ACL on MRI but the surgeon diagnoses the patient with a complete unilateral tear based on the clinical criteria above, then the patient will be considered eligible. Final eligibility will be determined intra-operatively.) Exclusion Criteria: - - ACL rupture on contra-lateral limb - Partially torn ACL *final determination made intra-operatively - Concomitant medial collateral, lateral collateral, or posterior collateral ligament tears requiring surgical repair *final determination made intra-operatively - Severe chondromalacia (Grade IV on the ICRS scale) *final determination made intra-operatively - ACL reconstruction using allograft tissue - Confirmed connective tissue disorder - Unwillingness to be followed for 24 months post-operatively - History of rheumatoid arthritis - Pregnancy (at the time of surgery) - Psychiatric illness that precludes informed consent - Unable to speak, read or understand the English language - Major medical illness (life expectancy less than 1 year or unacceptably high operative risk)

Study Design


Related Conditions & MeSH terms

  • Anterior Cruciate Ligament Rupture
  • Rupture

Intervention

Procedure:
ACL reconstruction - graft choice
Use of 3 different ipsilateral autograft options

Locations

Country Name City State
Canada Pan Am Clinic Winnipeg Manitoba

Sponsors (1)

Lead Sponsor Collaborator
Panam Clinic

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary graft re-injury (re-rupture, partial tear) or graft failure ) Diagnosis of a complete graft re-rupture requires all of the following criteria to be met:
associated with an acute traumatic event
a definite loss of end point on manual Lachman testing
increased anterior translation >3 mm
> or = Grade 2 pivot shift
tear confirmed as complete on MRI or diagnostic arthroscopy
revision ACL reconstruction IS recommended or required
2) Diagnosis of a partial re-rupture requires all of the following criteria:
suspected meniscal injury or graft tear on history without the clinical characteristics of a complete rupture
tear confirmed as partial by MRI or diagnostic arthroscopy
revision ACL reconstruction is NOT recommended or required
3) Diagnosis of graft failure will be defined as:
>/= Gr. 2 pivot shift and/or >6 mm side-to-side difference on manual Lachman
24 months
Secondary SANE 24 months
Secondary Knee laxity KT1000 Knee Laxity Arthrometer 24 months
Secondary Concentric maximal strength Knee flexion and extension strength - biodex 24 months
Secondary Pain log type and quantity of pain medication use 3 weeks post operative
Secondary ACL-QOL 24 months
Secondary SF-12 24 months
See also
  Status Clinical Trial Phase
Recruiting NCT05487768 - Functional Connectivity After Anterior Cruciate Ligament Reconstruction N/A
Recruiting NCT04390035 - BFRT in Adolescents After ACL Reconstruction N/A
Recruiting NCT02740452 - Anterior Cruciate Ligament Rupture N/A
Not yet recruiting NCT02555917 - Comparison of Remnant Preserving Versus Remnant Resecting Anterior Cruciate Ligament Reconstruction N/A
Active, not recruiting NCT00529958 - Comparison of Three Methods for Anterior Cruciate Ligament Reconstruction N/A
Completed NCT05109871 - Reliability and Validity of Inline Dynamometry Study for Measuring Knee Extensor Torque N/A
Not yet recruiting NCT06048874 - FNB in ACL Recon Under SA N/A
Not yet recruiting NCT06048848 - FNB in ACL Recon Under GA N/A
Terminated NCT03529552 - Evaluation After Reconstruction of the Anterior Cruciate Ligament of the Knee Using the Bioresorbable Interference Screw (SMS): Resorbability, Per- and Post-operative Complications and Articular Functional Recovery. N/A
Completed NCT04285853 - Are Opioids Needed After ACL Reconstruction Phase 4
Recruiting NCT04088227 - Effects of Platelet Rich Plasma Injections on Biomarkers After Anterior Cruciate Ligament Tears Phase 2
Not yet recruiting NCT04953676 - A Clinical Trial of the Round-tunnel and Flat-tunnel Technique of ACL Reconstruction N/A
Not yet recruiting NCT04957706 - Diagnostic Study of ACL Rupture With Anterior Drawer Test at 90° of Hip Flexion
Enrolling by invitation NCT03365908 - Pain Management of ACL Reconstruction N/A
Recruiting NCT06030791 - BTB Graft Harvest and Donor Site Morbidity After ACL Reconstruction
Recruiting NCT03950024 - Improvement of Knowledge About the Arthrogenic Muscle Inhibition in the Aftermath of Knee Trauma. N/A
Recruiting NCT03229369 - Association of ALL and ACL Reconstruction Versus Isolated ACL Reconstruction in High-risk Population: a RCT. N/A
Completed NCT01267435 - Evaluation of Tibial and Femoral Tunnel Position After Arthroscopic Reconstruction of the Anterior Cruciate Ligament Phase 2
Completed NCT05057442 - The Effects of Remnant-Preserving Anterior Cruciate Ligament Reconstruction on Proprioception and Functionality
Completed NCT04393129 - Central Sensitization Symptoms and Psychosocial Factors in Athletes After ACL Reconstruction